CinCor Pharma, Inc.
CinCor Pharma, Inc. (CINC) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001868734 · CINC · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001868734 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
CinCor Pharma, Inc. (NASDAQ: CINC) has submitted 141 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001868734, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is CinCor Pharma, Inc.'s most comprehensive regulatory disclosure. The most recent CinCor Pharma, Inc. 10-K was filed on 2022-03-22 for fiscal year ending 2022. Historical CINC 10-K annual reports are available from 2021 through 2022.
Investors researching CinCor Pharma, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CINC SEC Filings · 8 questionsCinCor Pharma, Inc. (CINC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 141 filings and access original documents at no cost. CinCor Pharma, Inc.'s CIK is 0001868734.